Wren Alison M
Department of Endocrinology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Front Horm Res. 2008;36:165-181. doi: 10.1159/000115364.
Following the discovery of secretin in 1902, a host of further peptide hormones that are synthesised and released from the gastrointestinal tract have been identified. While their roles in the regulation of gastrointestinal function have been known for some time, it is now evident that many of these hormones also physiologically regulate energy balance. Our understanding of how gut hormones signal to the brain has advanced significantly in recent years. Several hormones, including peptide YY, pancreatic polypeptide, oxyntomodulin, glucagon-like peptide 1 and cholecystokinin function as satiety signals. In contrast, only ghrelin, produced by the stomach, has emerged as a putative hunger signal, appearing to act both as a meal initiator and a long-term body weight regulator. Recent research suggests that gut hormones can be manipulated to regulate energy balance in man and that obese subjects retain sensitivity to the actions of gut hormones. The worldwide obesity pandemic continues unabated, despite public health initiatives and current best therapy. Future gut hormone-based therapies may provide an effective and well-tolerated treatment for obesity.
1902年发现促胰液素后,人们又鉴定出了许多由胃肠道合成并释放的肽类激素。虽然它们在调节胃肠功能方面的作用已为人所知有一段时间了,但现在很明显,其中许多激素在生理上也调节能量平衡。近年来,我们对肠道激素如何向大脑发出信号的理解有了显著进展。几种激素,包括肽YY、胰多肽、胃动素、胰高血糖素样肽1和胆囊收缩素,都起着饱腹感信号的作用。相比之下,只有胃产生的胃饥饿素已成为一种公认的饥饿信号,似乎既能启动进食,又能长期调节体重。最近的研究表明,可以通过调节肠道激素来调节人类的能量平衡,而且肥胖受试者对肠道激素的作用仍保持敏感。尽管有公共卫生倡议和当前的最佳治疗方法,但全球肥胖流行仍未减弱。未来基于肠道激素的疗法可能为肥胖提供一种有效且耐受性良好的治疗方法。